Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)

The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across NHGRIs scientific areas and will incorporate a plan for strategies to facilitate inclusive and diverse perspectives. Applications from New or Early Stage Investigators from diverse backgrounds are encouraged. This R21 FOA will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate the transition to research independence of diverse New Investigators. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.